FDA ADE reports for Glipizide

ade_glipizide_adverse_events

ade en 2026-07-22

Glipizide — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Glipizide is a active ingredient.

Total reports

Glipizide: 21

Reports by species (top entries)

Cat 12
Human 7
Dog 1
Monkey 1

Top reported reactions (VEDDRA terms, top entries)

Ketosis 5
Lethargy (see also Central nervous system depression in Neurological) 4
Accidental exposure 3
Decreased appetite 3
Vomiting 3
Anxiety 2
Behavioural disorder NOS 2
Death 2
Death by euthanasia 2
Diabetic ketoacidosis 2

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b27.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).

Sources

FDA ADE reports for Glipizide (active ingredient) — total reports, species & reaction breakdown

Source document: FDA FAERS / openFDA Animal & Veterinary Event Reports

US FDA Center for Veterinary Medicine (openFDA animal & veterinary event database)retrieved 2026-07-22

Verification file: pdf-raw/ade/ade_active_ingredients_2026-07-22_b27.json

Link points to the issuing authority's site; a direct document link is still being verified.

Machine access

AI agents: this page mirrors GET /api/v1/llm_context?topic=ade_glipizide_adverse_events (max 500 tokens, whitelisted). Rate limit 60 req/min for recognized AI crawlers.

Raw JSON ↗ llm.txt OpenAPI